-+ 0.00%
-+ 0.00%
-+ 0.00%

ALUMIS INC - TOPLINE DATA FROM LUMUS PHASE 2B TRIAL OF ENVUDEUCITINIB IN SLE EXPECTED TO BE ANNOUNCED IN Q3 2026

Reuters·01/06/2026 12:01:02

Please log in to view news